Literature DB >> 13684972

Novobiocin-tetracycline in the treatment of ear, nose and throat infections.

J L ATKINS.   

Abstract

Entities:  

Keywords:  NOVOBIOCIN/therapy; OTORHINOLARYNGOLOGY/therapy; TETRACYCLINE/therapy

Mesh：

Substances：

Year:  1960        PMID： 13684972      PMCID： PMC1938778     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN： 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  7 in total

1.  Treatment of soft-tissue infections in children with an antibiotic combination, tetracycline and novobiocin with metaphosphate.

Authors:  A G BAADJ; F J LOPERFIDO; A PRIGOT
Journal:  Antibiotic Med Clin Ther (New York)       Date:  1958-11

2.  Current therapeutics. CXIV. Novobiocin.

Authors:  M FINLAND; R L NICHOLS
Journal:  Practitioner       Date:  1957-07

3.  Severe reactions to antibiotics; a nationwide survey.

Authors:  H WELCH; C N LEWIS; H I WEINSTEIN; B B BOECKMAN
Journal:  Antibiotic Med Clin Ther (New York)       Date:  1957-12

4.  Use of a new tetracycline-novobiocin combination in the treatment of various types of infections.

Authors:  N A DAVID; W R DAY
Journal:  Antibiotic Med Clin Ther (New York)       Date:  1958-02

5.  Treatment of cutaneous infections with tetracycline-novobiocin combination.

Authors:  L C GOLDBERG
Journal:  Antibiotic Med Clin Ther (New York)       Date:  1958-02
  7 in total
  2 in total

1.  Novobiocin-Tetracycline in the Treatment of Ear, Nose and Throat Infections.

Authors:  G H Holman
Journal:  Can Med Assoc J       Date:  1960-12-17       Impact factor: 8.262

2.  Effect of novobiocin and its combination with tetracycline, chloramphenicol, erythromycin, and lincomycin on the microbial generation of Escherichia coli.

Authors:  E R Garrett; C M Won
Journal:  Antimicrob Agents Chemother       Date:  1973-12       Impact factor: 5.191
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.